Companies / Alamar Biosciences
Alamar Biosciences
Company
Alamar Biosciences develops and provides proteomics products and services, including assays and analysis solutions for various fields such as immunology, neurology, and oncology.
Alamar Biosciences has 3 investors on file, among them ARK Venture Fund, Illumina Ventures and Qiming Venture Partners. Its site was last checked 13 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
1 headline naming Alamar BiosciencesEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Alamar Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ARK Venture Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/alamarbio.com/investors
# also
GET /v1/companies/alamarbio.com
GET /v1/companies/alamarbio.com/news